We are live on
!
Find out more
JAFL
Jay A. Fishman Ltd Portfolio holdings
AUM
$1.26B
1-Year Est. Return
31.39%
This Fund
S&P 500
This Quarter
Est. Return
+14.41%
1 Year Est. Return
+31.39%
3 Year Est. Return
+105.23%
5 Year Est. Return
+150.45%
10 Year Est. Return
+706.68%
AUM
$825M
AUM Growth
+$42.3M
(+5.4%)
Cap. Flow
-$52.2M
Cap. Flow
% of AUM
-6.32%
Top 10 Holdings %
Top 10 Hldgs %
67.92%
Holding
103
New
10
Increased
17
Reduced
46
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMA
Comerica
CMA
|
+$10.8M |
| 2 |
Merck
MRK
|
+$4.9M |
| 3 |
Zoetis
ZTS
|
+$2.56M |
| 4 |
Icahn Enterprises
IEP
|
+$2.35M |
| 5 |
Eli Lilly
LLY
|
+$1.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$16.5M |
| 2 |
AbbVie
ABBV
|
+$13.7M |
| 3 |
JPMorgan Chase
JPM
|
+$6.14M |
| 4 |
Johnson & Johnson
JNJ
|
+$4.88M |
| 5 |
Blackstone
BX
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.33% |
| 2 | Financials | 14.39% |
| 3 | Industrials | 12.41% |
| 4 | Healthcare | 12.15% |
| 5 | Consumer Discretionary | 10.94% |
Similar funds
HP
DAM
PIA
DP
TBC
TCA
TWP
NCM
Jay A. Fishman Ltd's Q2 2023 Portfolio in Review
As of Q2 2023, Jay A. Fishman Ltd held 103 positions worth $825M, up 5.4% from $783M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Jay A. Fishman Ltd withdrew a net $52.2M in Q2 2023, closing 5 positions and reducing 46 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $1.97M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Industrials.
Against the trend, Jay A. Fishman Ltd opened a new position in Comerica worth $11.4M.
- Jay A. Fishman Ltd's largest Q2 2023 buy was Comerica: 268,325 shares worth $11.4M.
- Jay A. Fishman Ltd added most to Merck in Q2 2023, an estimated $4.9M increase.
- Jay A. Fishman Ltd's biggest Q2 2023 reduction was Apple, cutting an estimated $16.5M.
- Jay A. Fishman Ltd fully exited Bristol-Myers Squibb in Q2 2023, selling an estimated $1.97M.
- Jay A. Fishman Ltd's ten largest holdings make up 68% of its $825M portfolio in Q2 2023.
- Jay A. Fishman Ltd opened 10 new positions and closed 5 in Q2 2023.
- Jay A. Fishman Ltd's portfolio value rose 5.4% quarter-over-quarter to $825M.
Based on Jay A. Fishman Ltd's 13F filing for Q2 2023, filed 15 Aug 2023.